VanEck Biotech ETF
BBH
116 hedge funds and large institutions have $169M invested in VanEck Biotech ETF in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 33 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
12% more capital invested
Capital invested by funds: $152M → $169M (+$17.9M)
5% more funds holding
Funds holding: 110 → 116 (+6)
1.78% more ownership
Funds ownership: 33.56% → 35.35% (+1.8%)
33% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 33
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$9.82M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$8.75M |
| 3 |
JP Morgan Chase
New York
|
+$2.81M |
| 4 |
FFN
Focus Financial Network
Minneapolis,
Minnesota
|
+$2.17M |
| 5 |
Corient Private Wealth
Miami,
Florida
|
+$992K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
-$11.2M |
| 2 |
LPL Financial
San Diego,
California
|
-$3.41M |
| 3 |
FFP
FourThought Financial Partners
Venice,
Florida
|
-$615K |
| 4 |
PGFC
Peapack-Gladstone Financial Corp
Bedminster,
New Jersey
|
-$547K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$465K |
BBH Hedge Fund Activity: Q4 2023 in Review
116 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2023, worth a combined $169M — up 12% from $152M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BBH positions and 9 closed out — a net gain of 8 holders — while 22 added to existing stakes and 33 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $9.82M. The largest seller was Miller Investment Management, cutting an estimated $11.2M.
- 116 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2023, up from 110 in Q3 2023.
- Funds reported $169M of VanEck Biotech ETF stock for Q4 2023, up 12% quarter-over-quarter.
- 17 funds opened new VanEck Biotech ETF positions in Q4 2023 and 9 closed out, a net change of +8 holders.
- The largest VanEck Biotech ETF buyer in Q4 2023 was Morgan Stanley, an estimated $9.82M added.
- The largest VanEck Biotech ETF seller in Q4 2023 was Miller Investment Management, an estimated $11.2M sold.
Based on aggregated 13F filings for Q4 2023.